Enrich Biosystems key facts
as of Oct 2026- Developer of a novel single-cell isolation technology designed to enhance biomedical research at a true single-cell level.
- Enrich Biosystems is valued at approximately $11.9M as of Oct 2026 (last reported valuation).
- It has raised $8.6M across 3 recorded rounds; the latest was Debt ($1.4M) in Nov 2025.
- Notable investors include MedTech Innovator, National Institutes of Health, Connecticut Innovations, Decent Capital, BioTools Innovator — 15 tracked in total.
- Enrich Biosystems has filed 2 Form Ds with the SEC, most recently May 2024 ($750K sold to 10 investors).
- Status: Privately Held (backing).
Enrich Biosystems's last reported valuation, May 2022. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch Enrich Biosystems: the Monday email on marks, rounds and moves
Enrich Biosystems funding rounds
3 roundsWho backs Enrich Biosystems
15+Membership and data by Private Market View
Enrich Biosystems valuation
Enrich Biosystems's last reported valuation was $11.9 million in May 2022. No priced round, secondary trade or fund mark has surfaced since.
How much has Enrich Biosystems raised?
Enrich Biosystems has raised $8.6 million across 3 recorded rounds since 2024. The largest was a $750,000 seed round in May 2024; the most recent was a $1.4 million debt round in Nov 2025.
Enrich Biosystems has filed 2 Form Ds with the SEC, most recently in May 2024 ($750,000 sold to 10 investors).
Enrich Biosystems investors
15 investors are on record for Enrich Biosystems, including MedTech Innovator, National Institutes of Health, Connecticut Innovations and Decent Capital. The debt round in Nov 2025 drew 4 investors.
About Enrich Biosystems
Developer of a novel single-cell isolation technology designed to enhance biomedical research at a true single-cell level. The company's technology uses non-fluidics, dissolvable microwells and visual enrichment strategies to eliminate insurmountable pain points from existing technologies, enabling healthcare professionals to get a streamlined workflow of cell culturing, kinetics profiling and guided capturing based on cell functions.
- Sector
- Healthcare
- HQ
- Branford, CT, United States
- Founded
- 2018
- Employees
- 14
- Website
- enrichbiosystems.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.